Riverview Capital Advisers’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Buy
2,972
+39
+1% +$6.34K 0.15% 60
2025
Q4
$572K Sell
2,933
-52
-2% -$12.4K 0.17% 60
2025
Q3
$839K Buy
2,985
+1,606
+116% +$409K 0.24% 57
2025
Q2
$301K Buy
+1,379
New +$223K 0.09% 82
2025
Q1
Sell
-1,462
Closed -$244K 95
2024
Q4
$244K Buy
1,462
+3
+0.2% +$533 0.07% 87
2024
Q3
$249K Buy
1,459
+4
+0.3% +$579 0.08% 81
2024
Q2
$205K Sell
1,455
-429
-23% -$53.3K 0.07% 81
2024
Q1
$237K Buy
+1,884
New +$216K 0.08% 78
2023
Q3
Sell
-1,866
Closed -$222K 82
2023
Q2
$222K Buy
+1,866
New +$193K 0.1% 76
2022
Q2
Sell
-1,777
Closed -$147K 93
2022
Q1
$147K Buy
1,777
+6
+0.3% +$486 0.07% 88
2021
Q4
$154K Buy
+1,771
New +$166K 0.07% 92

Other funds holding ORCL

Riverview Capital Advisers's ORCL Position: Q1 2026 in Review

Riverview Capital Advisers increased its Oracle (ORCL) stake by 1.3% in Q1 2026, buying an estimated $6.34K and bringing the position to 2,972 shares worth $437K. The position accounts for 0.15% of the portfolio, ranked #60.

Riverview Capital Advisers first reported a position in ORCL in Q4 2021 and has held it in 11 quarters since. The position peaked at $839K in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Riverview Capital Advisers held 2,972 shares of Oracle worth $437K as of Q1 2026.
  • Riverview Capital Advisers bought 39 Oracle shares in Q1 2026, an estimated $6.34K.
  • Oracle made up 0.15% of Riverview Capital Advisers's portfolio in Q1 2026, its #60 holding.
  • Riverview Capital Advisers first reported a position in Oracle in Q4 2021 and has held it in 11 quarters since.
  • Riverview Capital Advisers's Oracle position peaked at $839K in Q3 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Riverview Capital Advisers's 13F filing for Q1 2026, filed 14 May 2026.